AzTrials
AzTrials

Supraspinatus TendinitisRESWTHPPTUNCT05192746

Radial Extracorporeal Shock Wave Therapy Versus High Power Pain Threshold Ultrasound Therapy in Supraspinatus Tendinitis

A study testing extracorporeal shock wave therapy and high power pain threshold ultrasound in people with Supraspinatus Tendinitis, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Extra corporeal shock wave therapy is a treatment method in which high-amplitude sound waves are focused on the targeted body tissue Recently, Extra corporeal shock wave therapy has been proposed as an alternative treatment in patients not responding to pharmaceutical treatment.High power pain threshold ultrasound is… Read more about this study

Who is it for?
Ages 30 to 50 years
Conditions the study is for
Supraspinatus Tendinitis
What is being tested?
extracorporeal shock wave therapy and high power pain threshold ultrasound
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
No sites listed yet
Study dates
Jan 2022to Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients' age ranges from 30 to 50 years old.
  • Patients are males and females.
  • BMI of all subjects were <30 Kg/m2.
  • Patients will be diagnosed as supraspinatus tendinitis.
  • All patients are medically stable.
  • All patients should be conscious and ambulant.
Show all 9Show fewer
  • Patients don't have any nervous system problems
  • Patients don't have shoulder disorder other than tendenities
  • Patients that didn't undergo any surgery in shoulder joint

Who cannot join

  • • Patients who received intra articular injection from duration less than 3 months.
  • Patients with supraspinatus tendonitis secondary to trauma.
  • Patients with metal implants.
  • Patient who had malignancy in the affected area.
  • Patient with acute infection in the treated area.
  • Diabetic patients
Show all 11Show fewer
  • Bone infection
  • Shoulder instability
  • Epilepsy
  • Coagulation diseases
  • Rheumatological diseases (rheumatoid arthritis and gouty arthritis)

About this study

Official title: Radial Extracorporeal Shock Wave Therapy Versus High Power Pain Threshold Ultrasound Therapy on Pain,Pressure Threshold Supraspinatus Trigger Point

Extra corporeal shock wave therapy is a treatment method in which high-amplitude sound waves are focused on the targeted body tissue Recently, Extra corporeal shock wave therapy has been proposed as an alternative treatment in patients not responding to pharmaceutical treatment.High power pain threshold ultrasound is the use of therapeutic ultrasound in a continuous mode; with the probe placed directly on affected area (supraspinatus tendon)

Read the detailed description

Shock wave therapy is an effective method of dissolving calcification and stimulating tissue healing. Extra corporeal shock wave therapy is a treatment method in which high-amplitude sound waves are focused on the targeted body tissue Recently, Extra corporeal shock wave therapy has been proposed as an alternative treatment in patients not responding to pharmaceutical treatment.US have been widely used for more than 40 years in the treatment of musculoskeletal disorders such as tendinitis, tenosynovitis, epicondylitis, bursitis and osteoarthritis. High power pain threshold ultrasound is the use of therapeutic ultrasound in a continuous mode; with the probe placed directly on affected area (supraspinatus tendon) "the intensity of ultrasound is first increased to the threshold pain level (to 1.5 W/cm) and then reduced to one half of that intensity. It was kept at that level for 4 to 5 seconds and then reduced to the half-intensity level for another 15 seconds .

Being tested
control group, extracorporeal shock wave therapy, high power pain threshold ultrasound
Keywords
extracorporeal shock wave, high power pain threshold ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • control groupOther

    Exercise Therapy and hot pack This tendon exercise program is very effective if done consistently. There are five steps to the program: warm up, stretching exercise, strengthening exercise, stretching exercise, and heat.

  • extracorporeal shock wave therapyDevice

    Shock Master 500 device will be applied once a week for four weeks in total. Each treatment consists of 2000 shocks 3 bar pressure, 20 Hz. Each rESWT session will take about 10 minutes. rESWT application will be performed on the supraspinatus trigger point. In successive treatments, there will be using of an energy density equal to 0.28 mJ/mm2

  • high power pain threshold ultrasoundDevice

    High-power, pain-threshold, ultrasound therapy application (in W/cm2) in continuousmodes, to elicit threshold pain, the ultrasound probe must be kept static on the tendon.

    Intensity will be gradually increased to the level of maximum pain the patient could bear. It will be kept at that level for 4 to 5 seconds and then will be reduced to the half-intensitylevel for another 15 seconds. This procedure will be repeated 3 times.High-power,

Study groups in NCT05192746
Study groupRoleWhat they receive
group A "Control group"ExperimentalTwenty two patients will receive conventional treatment hot pack and exercise (control group). .
Receives: Other: control group
group B"Extracorporeal shock wave group":ExperimentalTwenty two patients will receive Radial Extra corporeal Shock Wave Therapy plus conventional treatment hot pack and exercise.
Receives: Device: extracorporeal shock wave therapy
Group C"High power pain threshold ultrasound group":ExperimentalTwenty two patients will receive High-Power Pain Threshold Ultrasound therapy plus conventional treatment hot pack and exercise
Receives: Device: high power pain threshold ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 1. pain intensity[Time Frame:]

    pain will be measured by visual analogue scale higher score mean worse outcome ten centimeter line from zero to ten, zero mean no pain and ten mean maximum pain

    Measured: up to four weeks

  2. 2.range of motion

    range of motion will be measured by gravititional inclinometer

    Measured: up to four weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2022
  2. Study startJan 2022 (estimated)
  3. Primary completionOct 2022 (estimated)
  4. Study completionOct 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
pre post intervention study
Masking
None (open label)
Enrolment
66 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05192746
Sponsor's protocol ID
P.T.REC/120/03319
Acronym
RESWTHPPTU
Status last verified
Dec 2021
First submitted
27 Oct 2021
Last updated
14 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing extracorporeal shock wave therapy and high power pain threshold ultrasound in people with Supraspinatus Tendinitis, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

1. pain intensity[Time Frame:] (time frame: up to four weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in